Effect of ibuprofen on the development of fat-induced atherosclerosis in New Zealand rabbits

Journal of Experimental Animal Science

Volumn 43, Issue 4, 2007, Pages 283-299

  Sekalska, B ^a   Ciechanowicz, A ^b   Dolegowska, B ^b   Naruszewicz, M ^b  

^a WEST POMERANIAN UNIVERSITY OF TECHNOLOGY   (Poland)

^b POMERANIAN MEDICAL UNIVERSITY   (Poland)

Author keywords

Atherosclerosis; Ibuprofen; Monocyte chemotactic protein type 1 (MCP 1); Rabbit; Reverse transcription polymerase chain reaction

Indexed keywords

CELL ADHESION MOLECULE; CHEMOKINE; CHOLESTEROL; IBUPROFEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; NONSTEROID ANTIINFLAMMATORY AGENT; RNA; TRIACYLGLYCEROL; TUMOR NECROSIS FACTOR ALPHA;

ADRENAL GLAND; ANIMAL EXPERIMENT; ANIMAL FOOD; ANIMAL MODEL; ANIMAL TISSUE; ARTERY ENDOTHELIUM; ARTICLE; ATHEROSCLEROSIS; ATHEROSCLEROTIC PLAQUE; BODY MASS; CELL ACTIVATION; CELL MIGRATION; CHOLESTEROL DIET; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENDOTHELIUM CELL; FAT INTAKE; FOAM CELL; GENETIC REGULATION; IN VIVO STUDY; INFLAMMATION; LIVER WEIGHT; LOW DRUG DOSE; MALE; MONOCYTE; NONHUMAN; ORGAN WEIGHT; PATHOGENESIS; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; RABBIT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; STEM CELL; TREATMENT DURATION; TREATMENT FAILURE;

ORYCTOLAGUS CUNICULUS;

EID: 33846581881     PISSN: 09398600     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jeas.2006.10.001     Document Type: Article

References (48)

1. Adams S.S., Bresloff P., and Mason C.G. Pharmacological differences between the optical isomers of ibuprofen: evidence for metabolic inversion of the (-) -isomer. J. Pharm. Pharmacol. 28 (1976) 256-257
2. Anitschkow N. Über die veränderungen der kaninchenaorta bei experimenteller cholesterinsteatose. Beitr. Pathol. Anat. 56 (1913) 379-404
3. Avgerinos A., and Hutt A.J. Interindividual variability in the enantiomeric disposition of ibuprofen following the oral administration of the racemic drug to healthy volunteers. Chirality 3 (1990) 249-256
4. Betz E., and Schlote W. Responses of vessel walls to chronical applied electrical stimuli. Basic Res. Cardiol. 74 (1979) 10-20
5. Chomczynski P. A reagent for the single-step simultaneous isolation of RNA, DNA and proteins from cell and tissue samples. Biotechniques 15 (1993) 536-537
6. Efsen E., Bonacchi A., Pastacaldi S., Valente A.J., Wenzel U.O., Tosti-Guerra C., Pinzani M., Laffi G., Abboud E., Gentilini P., and Marra F. Agonist-specific regulation of monocyte chemoattractant protein-l expression by cyclooxygenase metabolites in hepatic stellate cells. Hepatology 33 (2001) 713-721
7. Esper E., Runge W.J., Gunther R., and Buchwald H. Natural history of atherosclerosis and hyperlipidemia in heterozygous WHHL (WHHL-Hh) rabbits. II. Morphologic evaluation of spontaneously occuring aortic and coronary lesions. J. Lab. Clin. Med. 121 (1993) 103-110
8. Evans A.M. Comparative pharmacology of S(+)-ibuprofen and (RS)-ibuprofen. Clin. Rheumatol. 20 1 (2001) S9-S14
9. Finking G., and Hanke H. Nikolaj Nikolajewitsch Anitschkow (1885-1964) established the cholesterol-fed rabbit as a model for atherosclerosis research. Atherosclerosis 135 (1997) 1-7
10. Foxworthy P.S., Perry D.N., and Eacho P.I. Iduction of perixisomal beta-oxidation by nonsteroroidal anti-inflammatory drugs. Toxicol. Appl. Pharmacol. 118 2 (1993) 271-274
11. Fruebis J., Silvestre M., Shelton D., Napoli C., and Palinski W. Inhibition of VCAM-1 expression in the arterial wall is shared by structurally different antioxidants that reduce early atherosclerosis in NZW rabbits. J. Lipid Res. 40 (1999) 1958-1966
12. Gandhi V.M., and Mulky M.J. Effect of taurine on triton WR 1339 induced hyperlipidaemia in rats. Indian J. Pharmacol. 25 (1993) 237-239
13. Główka F.K. Stereoselective pharmacokinetics of ibuprofen and its lysinate from suppositories in rabbits. Eur. J. Pharmacol. 199 (2000) 159-166
14. Graves D.T., Jiang Y.L., Wiliamson M.J., and Valente A.J. Identification of monocyte chemotactic activity produced by malignant cells. Science 245 (1989) 1490-1493
15. Herman T., Flig E., and Główka F. Studies on the metabolism of ibuprofen in insolated rat hepatocytes. Acta Pol. Pharm. 54 3 (1997) 197-202
16. Hodis H.N., Crawford D.W., and Sevanian A. Cholesterol feeding increases plasma and aortic tissue cholesterol oxide levels in parallel: further evidence for the role of cholesterol oxidation in atherosclerosis. Atherosclerosis 89 (1991) 117-126
17. Hofbauer R., Speiser W., and Kapiotis S. Ibuprofen inhibits leukocyte migration through endothelial cell monolayers. Life Sci. 62 19 (1998) 1775-1781
18. Jamali F., Mehvar R., Russell A.S., Sattari S., Yakimets W.W., and Koo J. Human pharmacokinetics of ibuprofen enantiomers following different doses and formulations: intestinal chiral inversion. J. Pharm. Sci. 81 (1992) 221-225
19. Kapiotis S., Sengoelge G., Sperr W.R., Baghestanian M., Quehenberger P., Bevec D., Li S.R., Menzel E.J., Mlihl A., Zapolska D., Virgolini I., Valent P., and Speiser W. Ibuprofen inhibits pyrogen-dependent expression of VCAM-l and ICAM-l on human endothelial cells. Life Sci. 58 (1996) 2167-2181
20. Kavantzas N., Chatziioannou A., Yanni A.E., Tsakayannis D., Balafoutas D., Agrogiannis G., and Perrea D. Effect of green tea on angiogenesis and severity of atherosclerosis in cholesterol-fed rabbit. Vascul. Pharmacol. 44 (2006) 461-463
21. Kourounakis A.P., Victoratos P., Peroulis N., Stefanou N., Yiangou M., Hadjipetrou L., and Kouronakis P.N. Experimental hyperlipidemia and the effect of NSAIDs. Exp. Mol. Pathol. 73 (2002) 135-138
22. Mahley R.W., Innerarity T.L., Brown M.S., Ho Y.K., and Goldstein J.L. Cholesteryl ester synthesis in macrophages: stimulation by beta-very low density lipoproteins from cholesterol-fed animals of several species. J. Lipid Res. 21 (1980) 970-976
23. McCabe P.M., Gonzales J.A., Zaias J., Szeto A., Kumar M., Herron A.J., and Schneiderman N. Social environment influences the progression of atherosclerosclerosis in the Watanabe heritable hyperlipidemic rabbit. Circulation 105 (2002) 354-359
24. McGeer P.L., McGeer E.G., and Yasojima K. Expression of COX-l and COX-2 mRNAs in atherosclerosis plaques. Exp. Gerontol. 37 (2002) 925-929
25. Meir K., Leitersdorf E., and Hennekens C.H. Inflammation in atherosclerosis: causal or casual? The need for randomized trials. Am. Heart J. 146 2 (2003) 199-202
26. Mitchell J.A., and Warner T.D. Cyclooxygenase-2: pharmacology, physiology, biochemistry and relevance to NSAID therapy. Brit. J. Pharmacol. 128 (1999) 1121-1132
27. Naruse K., Shimizu K., Muramatsu M., Toki Y., Miyazaki Y., Okumura K., Hashimoto H., and Ito T. Long-term inhibition of NO synthesis promotes atherosclerosis in the hypercholesterolemic rabbit thoracic aorta. Arterioscler. Thromb. 14 (1994) 746-752
28. Navab M., Imes S.S., Hama S.Y., Hough G.P., Ross L.A., Bork R.W., Valente A.J., Berliner J.A., Drinkwater D.C., Laks H., and Fogelman A.M. Monocyte transmigration induced by modification of low density lipoprotein in co-cultures of human aortic wall cells is due to induction of monocyte chemotactic protein-1 synthesis and is abolished by high density lipoprotein. J. Clin. Invest. 88 (1991) 2039-2046
29. Nelken N.A., Coughlin S.R., Gordon D., and Wilcox J.N. Monocyte chemoattractant protein-1 in human atheromatous plaques. J. Clin. Invest. 88 (1991) 1121-1127
30. Nordestgaard B.G., and Zilversmit D.B. Large lipoproteins are excluded from the arterial wall in diabetic cholesterol-fed rabbits. J. Lipid Res. 29 (1988) 1491-1500
31. Rodrigueza W.V., Klimczuk S.K., Pritchard P.H., and Hope M.J. Cholesterol mobilization and regression of atheroma in cholesterol-fed rabbits induced by large unilamellar vesicles. Biochim. Biophys. Acta 1368 (1998) 306-320
32. Rosenfeld M.E., and Ross R. Macrophage and smooth muscle cell proliferation in atherosclerotic lesions of WHHL and comparably hypercholesterolemic fat-fed rabbits. Atheriosclerosis 10 (1990) 680-687
33. Ross R. Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340 (1999) 115-126
34. Scheuren N., Bang H., and Munster T. Modulation of transcription factor NF-κβ by enantiomers of the nonsteroidal drug ibuprofen. Br. J. Pharmacol. 123 (1998) 645-652
35. Soma M.R., Donetti E., Parolini C., Mazzini G., Ferrari C., Fumagalli R., and Paoletti R. HMG CoA reductase inhibitors. In vivo effects on carotid intimal thickening in normocholesterolemic rabbits. Arterioscler. Thromb. 13 (1993) 571-578
36. Stuhlmeier K.M., Li H., and Kao J.J. Ibuprofen: new explanation for an old phenomenon. J. Biochem. Pharmacol. 57 (1999) 313-320
37. Tan S.C., Patel B.K., Jackson S.H.D., Swift C., and Hutt A.J. Ibuprofen stereochemistry: double-the-trouble? 4 (1999) 195-203
38. Vane J.R., and Botting R.M. Mechanism of action of nonsteroidal anti-inflamatory drugs. Am. J. Med. 104 3A (1998) 2S-8S
39. Wallace J.L. Distribution and expression of cyclooxygenase (COX) isoenzymes, their physiological roles, and the categorization of nonsteroidal anti-inflammantory drugs (NSAIDs). Am. J. Med. 107 6A (1999) 11S-17S
40. Weidinger F.F., McLenachan J.M., Cybulsky M.I., Fallon J.T., Hollenberg N.K., Cooke J.P., and Ganz P. Hypercholesterolemia enhances macrophage recruitment and dysfunction of regenerated endothelium after ballon injury of the rabbit iliac artery. Circulation 84 (1991) 755-767
41. Wilensky R.L., March K.L., Gradus Pizlo I., Sandusky G., Fineberg N., and Hathaway D.R. Vascular injury, repair and restenosis after percutaneous transluminal angioplasty in the atherosclerotic rabbit. Curculation 92 (1995) 2995-3005
42. Yang A.L., Jen C.J., and Chen H.I. Effects of high-cholesterol diet and parallel exercise training on the vascular function of rabbit aortas: a time course study. J. Appl. Physiol. 95 3 (2003) 1194-1200
43. Yang Y., Bai G., Zhang X., Ye C., and Liu M. IH NMR spectroscopic evidence of interaction between ibuprofen and lipoproteins in human blood plasma. Anal. Biochem. 324 (2004) 292-297
44. Yla-Herttuala S., Lipton B.A., Rosenfeld M.E., Sarkioja T., Yoshimura R., Leonard E.J., Witztum J.L., and Steinberg D. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions. Proc. Natl. Acad. Sci. USA 88 (1991) 5252-5256
45. Yoshida N., Murase H., Kunieda T., Toyokuni S., Tanaka T., Terao J., Naito Y., Tanigawa T., and Yoshikawa T. Inhibitory effect of a novel water-soluble vitamin E derivative on atherosclerosis in rabbits. Atherosclerosis 162 (2002) 111-117
46. Yoshimura T.N., Yuhki N., Moore S.K., Apella E., Lerman M.I., and Leonard E.J. Human monocyte chemoattractant protein-1 (MCP-1): full length cDNA cloning, expression in mitogen-stimulated blood mononuclear leukocytes, and sequence similarity to mouse competence gene JE. FEBS Lett. 244 (1989) 487-493
47. Zapolska-Downar D., Zapolski-Downar A., Bukowska H., Modrzejewski A., and Naruszewicz M. Ibuprofen inhibits oxidative modification of low density lipoprotein. Atherosclerosis 134 1-2 (1997) 209
48. Zapolska-Downar D., Zapolski-Downar A., Markiewicz M., Bukowska H., Millo B., and Naruszewicz M. The effect of ibuprofen on monocyte function. Atherosclerosis 1 151 (2000) 198